Major step towards clarifying the risks and benefits of HRT Gill Higgins Newsletter Article 26 February 2013 Pages: 3 - 4
Anti-infective prophylaxis recommendations in neurosurgery Newsletter Article 26 February 2013 Pages: 5 - 5
…and the debate continues after 50 years of BCG vaccinations Newsletter Article 26 February 2013 Pages: 6 - 6
Positive results with ginkgolide B in Gram-negative sepsis Newsletter Article 26 February 2013 Pages: 8 - 8
Unique agent under development for CMV infection Gill Higgins Newsletter Article 26 February 2013 Pages: 9 - 10
T cell depletion a starting point for new SLE therapies Newsletter Article 26 February 2013 Pages: 10 - 10
Acetylcysteine in septic shock may increase survival Newsletter Article 26 February 2013 Pages: 12 - 12
New cyclosporin formulation reduces pharmacokinetic variability Rodger Hall Newsletter Article 26 February 2013 Pages: 13 - 14
Ondansetron effective for total body irradiation-induced emesis Newsletter Article 26 February 2013 Pages: 15 - 15
High-dose heparin beneficial for high-risk LV thrombi Newsletter Article 26 February 2013 Pages: 15 - 15
Low-dose aspirin preferable after mammary artery bypass grafting Newsletter Article 26 February 2013 Pages: 15 - 15
Low-dose interferon-α sufficient for chronic myeloid leukaemia Newsletter Article 26 February 2013 Pages: 16 - 16
Intranasal calcitonin keeps steroid-induced bone loss at bay Newsletter Article 26 February 2013 Pages: 17 - 17
Single-dose sumatriptan schedule takes first place Newsletter Article 26 February 2013 Pages: 18 - 18
Nasal buserelin improves final height in precocious puberty Newsletter Article 26 February 2013 Pages: 18 - 18
Neostigmine reverses neuromuscular blockade faster in children Newsletter Article 26 February 2013 Pages: 18 - 18
Electrophysiological effects of amiodarone and sotalol Newsletter Article 26 February 2013 Pages: 19 - 19
Bayesian analysis predicts oral theophylline dosage in children Newsletter Article 26 February 2013 Pages: 19 - 19